These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12108616)

  • 1. Efficacy of porcine secretin in children with autism and pervasive developmental disorder.
    Kern JK; Van Miller S; Evans PA; Trivedi MH
    J Autism Dev Disord; 2002 Jun; 32(3):153-60. PubMed ID: 12108616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.
    Lightdale JR; Hayer C; Duer A; Lind-White C; Jenkins S; Siegel B; Elliott GR; Heyman MB
    Pediatrics; 2001 Nov; 108(5):E90. PubMed ID: 11694674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism.
    Carey T; Ratliff-Schaub K; Funk J; Weinle C; Myers M; Jenks J
    J Autism Dev Disord; 2002 Jun; 32(3):161-7. PubMed ID: 12108617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.
    Corbett B; Khan K; Czapansky-Beilman D; Brady N; Dropik P; Goldman DZ; Delaney K; Sharp H; Mueller I; Shapiro E; Ziegler R
    Clin Pediatr (Phila); 2001 Jun; 40(6):327-31. PubMed ID: 11824175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism.
    Owley T; McMahon W; Cook EH; Laulhere T; South M; Mays LZ; Shernoff ES; Lainhart J; Modahl CB; Corsello C; Ozonoff S; Risi S; Lord C; Leventhal BL; Filipek PA
    J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1293-9. PubMed ID: 11699803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.
    Sandler AD; Sutton KA; DeWeese J; Girardi MA; Sheppard V; Bodfish JW
    N Engl J Med; 1999 Dec; 341(24):1801-6. PubMed ID: 10588965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of transdermal secretin on behavior of children with autism.
    Ratliff-Schaub K; Carey T; Reeves GD; Rogers MA
    Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretin and autism: a two-part clinical investigation.
    Chez MG; Buchanan CP; Bagan BT; Hammer MS; McCarthy KS; Ovrutskaya I; Nowinski CV; Cohen ZS
    J Autism Dev Disord; 2000 Apr; 30(2):87-94. PubMed ID: 10832772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.
    Sturmey P
    Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin.
    Levy SE; Souders MC; Wray J; Jawad AF; Gallagher PR; Coplan J; Belchic JK; Gerdes M; Mitchell R; Mulberg AE
    Arch Dis Child; 2003 Aug; 88(8):731-6. PubMed ID: 12876177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder.
    Kern JK; Miller VS; Cauller PL; Kendall PR; Mehta PJ; Dodd M
    J Child Neurol; 2001 Mar; 16(3):169-73. PubMed ID: 11305684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
    Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
    J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial.
    Roberts W; Weaver L; Brian J; Bryson S; Emelianova S; Griffiths AM; MacKinnon B; Yim C; Wolpin J; Koren G
    Pediatrics; 2001 May; 107(5):E71. PubMed ID: 11331721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of benefit of intravenous synthetic human secretin in the treatment of autism.
    Molloy CA; Manning-Courtney P; Swayne S; Bean J; Brown JM; Murray DS; Kinsman AM; Brasington M; Ulrich CD
    J Autism Dev Disord; 2002 Dec; 32(6):545-51. PubMed ID: 12553591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children with autistic spectrum disorders. II: parents are unable to distinguish secretin from placebo under double-blind conditions.
    Coplan J; Souders MC; Mulberg AE; Belchic JK; Wray J; Jawad AF; Gallagher PR; Mitchell R; Gerdes M; Levy SE
    Arch Dis Child; 2003 Aug; 88(8):737-9. PubMed ID: 12876178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of secretin on children with autism: a randomized controlled trial.
    Dunn-Geier J; Ho HH; Auersperg E; Doyle D; Eaves L; Matsuba C; Orrbine E; Pham B; Whiting S
    Dev Med Child Neurol; 2000 Dec; 42(12):796-802. PubMed ID: 11132252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism.
    Unis AS; Munson JA; Rogers SJ; Goldson E; Osterling J; Gabriels R; Abbott RD; Dawson G
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1315-21. PubMed ID: 12410073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder.
    Hollander E; Wasserman S; Swanson EN; Chaplin W; Schapiro ML; Zagursky K; Novotny S
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):541-8. PubMed ID: 17069543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.
    Coniglio SJ; Lewis JD; Lang C; Burns TG; Subhani-Siddique R; Weintraub A; Schub H; Holden EW
    J Pediatr; 2001 May; 138(5):649-55. PubMed ID: 11343038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments on "Secretin and autism: a two-part clinical investigation" by M.G. Chez et al.
    Rimland B
    J Autism Dev Disord; 2000 Apr; 30(2):95; discussion 97-8. PubMed ID: 10832773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.